These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 23809245)
1. Advanced precancerous lesions in the liver. Di Tommaso L; Sangiovanni A; Borzio M; Park YN; Farinati F; Roncalli M Best Pract Res Clin Gastroenterol; 2013 Apr; 27(2):269-84. PubMed ID: 23809245 [TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced computed tomography and ultrasound-guided liver biopsy to diagnose dysplastic liver nodules in cirrhosis. Iavarone M; Manini MA; Sangiovanni A; Fraquelli M; Forzenigo LV; Di Tommaso L; Aghemo A; Roncalli M; Ronchi G; Colombo M Dig Liver Dis; 2013 Jan; 45(1):43-9. PubMed ID: 23022425 [TBL] [Abstract][Full Text] [Related]
3. Stepwise carcinogenesis of hepatocellular carcinoma in the cirrhotic liver: demonstration on serial MR imaging. van den Bos IC; Hussain SM; Terkivatan T; Zondervan PE; de Man RA J Magn Reson Imaging; 2006 Nov; 24(5):1071-80. PubMed ID: 17024654 [TBL] [Abstract][Full Text] [Related]
4. [Advances in the study of cirrhosis and precancerous lesions of liver cancer]. Wu DB; Tang H Zhonghua Gan Zang Bing Za Zhi; 2019 Jul; 27(7):483-486. PubMed ID: 31357771 [TBL] [Abstract][Full Text] [Related]
5. New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm. Renzulli M; Biselli M; Brocchi S; Granito A; Vasuri F; Tovoli F; Sessagesimi E; Piscaglia F; D'Errico A; Bolondi L; Golfieri R Gut; 2018 Sep; 67(9):1674-1682. PubMed ID: 29437912 [TBL] [Abstract][Full Text] [Related]
6. Squamous cell carcinoma antigen in human liver carcinogenesis. Guido M; Roskams T; Pontisso P; Fassan M; Thung SN; Giacomelli L; Sergio A; Farinati F; Cillo U; Rugge M J Clin Pathol; 2008 Apr; 61(4):445-7. PubMed ID: 17893121 [TBL] [Abstract][Full Text] [Related]
7. Focal lesions in the cirrhotic liver: their pivotal role in gadoxetic acid-enhanced MRI and recognition by the Western guidelines. Golfieri R; Garzillo G; Ascanio S; Renzulli M Dig Dis; 2014; 32(6):696-704. PubMed ID: 25376286 [TBL] [Abstract][Full Text] [Related]
8. Latest developments in precancerous lesions of hepatocellular carcinoma. Niu ZS; Niu XJ; Wang WH; Zhao J World J Gastroenterol; 2016 Mar; 22(12):3305-14. PubMed ID: 27022212 [TBL] [Abstract][Full Text] [Related]
9. Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus. Hung CH; Hu TH; Lu SN; Kuo FY; Chen CH; Wang JH; Huang CM; Lee CM; Lin CY; Yen YH; Chiu YC Int J Cancer; 2016 Feb; 138(3):714-20. PubMed ID: 26264553 [TBL] [Abstract][Full Text] [Related]
10. The risk of hepatocellular carcinoma in cirrhotic patients with small liver nodules on MRI. Shah TU; Semelka RC; Pamuklar E; Firat Z; Gerber RD; Shrestha R; Russo MW Am J Gastroenterol; 2006 Mar; 101(3):533-40. PubMed ID: 16542290 [TBL] [Abstract][Full Text] [Related]
11. Classification tool for the systematic histological assessment of hepatocellular carcinoma, macroregenerative nodules, and dysplastic nodules in cirrhotic liver. Quaglia A; Jutand MA; Dhillon A; Godfrey A; Togni R; Bioulac-Sage P; Balabaud C; Winnock M; Dhillon AP World J Gastroenterol; 2005 Oct; 11(40):6262-8. PubMed ID: 16419153 [TBL] [Abstract][Full Text] [Related]
12. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis]. Tátrai P Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466 [TBL] [Abstract][Full Text] [Related]
13. Characterisation of dysplastic liver nodules using low-pass DNA sequencing and detection of chromosome arm-level abnormalities in blood-derived cell-free DNA. Fateen W; Johnson PJ; Wood HM; Zhang H; He S; El-Meteini M; Wyatt JI; Aithal GP; Quirke P J Pathol; 2021 Sep; 255(1):30-40. PubMed ID: 34028025 [TBL] [Abstract][Full Text] [Related]
14. [Dysplastic nodule of liver versus early hepatocellular carcinoma: a clinicopathologic and prognostic study]. Chen L; Tan Y; Zeng H; Hou Y; Xu J; Zhao J; Ji Y Zhonghua Bing Li Xue Za Zhi; 2014 May; 43(5):301-6. PubMed ID: 25030861 [TBL] [Abstract][Full Text] [Related]
15. Hepatic Precancerous Lesions and Early Hepatocellular Carcinoma. Wen KW; Kakar S Gastroenterol Clin North Am; 2024 Mar; 53(1):109-132. PubMed ID: 38280744 [TBL] [Abstract][Full Text] [Related]
16. Discrimination of cirrhotic nodules, dysplastic lesions and hepatocellular carcinoma by their vibrational signature. Peng C; Kaščáková S; Chiappini F; Olaya N; Sandt C; Yousef I; Samuel D; Dumas P; Guettier C; Le Naour F J Transl Med; 2016 Jan; 14():9. PubMed ID: 26754490 [TBL] [Abstract][Full Text] [Related]
17. Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis. Nault JC; Calderaro J; Di Tommaso L; Balabaud C; Zafrani ES; Bioulac-Sage P; Roncalli M; Zucman-Rossi J Hepatology; 2014 Dec; 60(6):1983-92. PubMed ID: 25123086 [TBL] [Abstract][Full Text] [Related]
18. Detection and characterization of hepatocellular carcinoma by imaging. Matsui O Clin Gastroenterol Hepatol; 2005 Oct; 3(10 Suppl 2):S136-40. PubMed ID: 16234062 [TBL] [Abstract][Full Text] [Related]
19. Hepatocellular dysplastic nodules. Roncalli M; Borzio M; Di Tommaso L Ann Ital Chir; 2008; 79(2):81-9. PubMed ID: 18727269 [TBL] [Abstract][Full Text] [Related]
20. Assessment of hemodynamics in precancerous lesion of hepatocellular carcinoma: evaluation with MR perfusion. Guan S; Zhao WD; Zhou KR; Peng WJ; Tang F; Mao J World J Gastroenterol; 2007 Feb; 13(8):1182-6. PubMed ID: 17451197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]